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S-layers are bacterial structures present on the surface of several Gram-positive and 
Gram-negative bacteria that play a role in bacterial protection. In Lactobacillus acidophilus 
(L. acidophilus ATCC 4356), the S-layer is mainly composed of the protein SlpA. A tandem 
of two copies of the protein domain SLP-A (pfam: 03217) was identified at the C-terminal 
of SlpA, being this double SLP-A protein domain (in short dSLP-A) necessary and sufficient 
for the association of the protein to the L. acidophilus cell wall. A variety of proteins fused 
to the dSLP-A domain were able to spontaneously associate with high affinity to the cell 
wall of L. acidophilus and Bacillus subtilis var. natto, in a process that we termed decoration. 
Binding of dSLP-A-containing-proteins to L. acidophilus was stable at conditions that 
mimic the gastrointestinal transit in terms of pH, proteases, and bile salts. To evaluate if 
protein decoration of L. acidophilus can be adapted to generate an oral vaccine platform, 
a chimeric antigen derived from the bacterial pathogen Shiga-toxin-producing Escherichia 
coli (STEC) was constructed by fusing the sequences encoding the polypeptides 
EspA36–192, Intimin653–953, Tir240–378, and H7 flagellin352–374 (EITH7) to the dSLP-A domain 
(EITH7-dSLP-A). Recombinantly expressed EITH7-dSLP-A protein was affinity purified 
and combined with L. acidophilus cultures to allow the association of the chimeric antigen 
to the bacterial surface. EITH7-decorated L. acidophilus was orally administered to BALB/c 
mice and the induction of anti-EITH7 specific antibodies in sera and feces determined by 
ELISA. Mice presenting significantly higher anti-EITH7 antibodies titers were able to control 
more efficiently an experimental STEC infection than mice that received the non-decorated 
L. acidophilus carrier, indicating that antigen-decorated L. acidophilus can be adapted 
as a mucosal immunization delivery platform to elicit a protective immune response for 
vaccine purposes.
Keywords: Lactobacillus, shiga toxigenic Escherichia coli, S-layer (fusion) proteins, oral vaccination, antigen 
delivery system
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INTRODUCTION
Vaccines have been the most successful medical therapy in 
Public Health preventing mortality and morbidity caused by 
several infectious diseases and saving millions of lives worldwide 
(Orenstein and Ahmed, 2017). Although most microbial 
pathogens enter the body through a particular mucosal barrier 
(gastrointestinal, respiratory, or genital mucosa) only a few 
vaccines using this route of administration have been approved, 
probably due to certain limitations in their protection 
performance (Lycke, 2012). It has been described that some 
oral vaccines performed poorly in developing countries compared 
with industrialized ones and this has been attributed to a 
syndrome named chronic environmental enteropathy (or tropical 
enteropathy). This syndrome is characterized by impairment 
in intestinal absorption that might lead to a reduction of 
bioavailability of zinc or vitamin A affecting the efficiency of 
adjuvant function and, therefore, impairing the induction of 
an effective immune response (Lycke, 2012). Another limitation 
related to oral administration of antigens is the natural proteolytic 
degradation that proteins suffer in the intestinal tract. Despite 
these limitations, oral immunization remains an ideal vaccine 
route to be explored, especially in global campaigns of vaccination; 
because its administration is simple (needleless administration) 
and non-medical trained personnel can perform it. Live vaccines 
based on attenuated microorganisms have been shown to be  a 
very effective way to elicit a protective immunity as a consequence 
of the ability of the vaccine strain to replicate inside the host 
resembling the real infection, therefore, providing an effective 
antigenic stimulation that leads to the development of a protective 
memory immune response. The selection of attenuated 
microorganisms has been historically a serendipitous process 
based on the sequential replication of a pathogen either in 
laboratory in vitro conditions or within a non-natural host in 
order to isolate non-virulent strains (Plotkin, 2014; Minor, 
2015). By this method, a few protective vaccines have been 
developed that have been widely used such as Oral Polio Virus 
(Sabin), BCG for tuberculosis, and the Yellow Fever vaccine 
YF17D (Galler et  al., 1997; Plotkin, 2014). Despite a better 
performance of live-attenuated vaccines to induce individual 
and population protection, there are certain limitations such 
as the latent possibility of reversion to a full virulence or the 
risk that the residual virulence of a vaccine strain might be still 
dangerous for immune-compromised individuals. In addition, 
not all the microbial pathogens can be  cultured in vitro and, 
in some cases, special biosafety facilities are also required, 
increasing production costs. To sort out these limitations, it 
has been proposed the use of vaccine strains as carriers for 
expressing heterologous antigens. Recently, a recombinant 
tetravalent vaccine against Dengue virus using the Yellow fever 
vaccine as a carrier was approved for humans, although, as a 
consequence of some complications that appeared during Phase 
III, the vaccine has had a limited use (Larson et  al., 2019). 
In the case of vaccines based on genetically modified organisms 
(GMOs), they are subjected to strict regulations to allow its 
administration to animals or humans increasing production 
costs considerably (Seib et  al., 2017).
Members of the Lactobacillus genus are considered as generally 
recognized as safe (GRAS) bacteria, since they are natural 
commensal bacteria that inhabit the gastrointestinal tract and 
genital mucosa and have been used for centuries in the 
preparation of fermented foods like yogurt, kefir, or sour cream. 
Given their mucosal localization, Lactobacillus species have 
been recently proposed as a recombinant carrier for oral vaccine 
development. For example, the human immunodeficiency virus 
(HIV) Gag, heat labile enterotoxin, rotavirus VP4, and the 
Helicobacter Adhesin Hp0410, have been expressed in 
Lactobacillus strains for vaccine purposes (Lecureux and Dean, 
2018). However, these Lactobacillus strains are DNA-recombinant 
vaccines, which affect their GRAS status.
When residing in the gut, some Lactobacillus species interact 
with host cells exerting a strain-specific immunomodulatory 
effect, that contributes to its probiotic properties (Hymes et al., 
2016; Johnson et  al., 2016; Douillard and de Vos, 2019). This 
immune-modulation has been attributed to the recognition of 
different microbial-associated molecular patterns (MAMPs) 
mediated by the pattern recognition receptors (PRRs), expressed 
in immune and non-immune host cells (Abou-Saleh et  al., 
2016; Hymes et al., 2016; Douillard and de Vos, 2019). MAMPs-
PRPs interaction triggers an inflammatory response, which is 
the main mechanism of action of adjuvants, such as the observed 
in the bacterium-like particles or Gram-positive enhancer 
matrixes used as antigen delivery platforms (Arce et  al., 2019). 
In this report, we  adapted Lactobacillus acidophilus as an oral 
vaccine platform to deliver heterologous antigens from a bacterial 
intestinal pathogen, the Shiga-toxin-producing Escherichia coli 
(STEC). STEC is a bacterial pathogen that causes hemorrhagic 
enteritis and the life-threatening hemolytic uremic syndrome 
(HUS) in humans (Goldwater, 2007). Immunization with STEC 
surface proteins (such as EspA, Tir, Intimin, or flagellin) induces 
an antibody humoral response that interferes with the effective 
STEC-host cell interaction. Based on this observation, two 
vaccine candidates have been developed for the prevention or 
reduction of STEC intestinal colonization in cattle (Potter et al., 
2004; Babiuk et  al., 2008). STEC deploys protein secretion 
machinery, the type three secretion system (T3SS), critical for 
host invasion and intestinal colonization. STEC T3SS is a 
“nanomachine” that the bacteria utilize to translocate effector 
proteins to the host cell cytosol to promote its tight association 
to the host cell surface. Initially, the effector protein Tir is 
“injected” by the STEC T3SS within the host cells and exposed 
on the host membrane, where it will be recognized by Intimin, 
a STEC outer membrane protein. When Tir interacts with 
Intimin, a host-signaling cascade is triggered that leads to the 
rearrangement of the intestinal epithelial cellular architecture, 
inducing the formation of actin “pedestals” beneath the attached 
bacteria. In addition, the T3SS effector protein EspA polymerizes 
forming a filamentous tip on the bacterial membrane which 
is essential for bacterial attachment and T3SS activity. Here, 
we  constructed a STEC chimeric antigen composed by the 
peptides EspA36–192, Intimin653–935 (containing the Tir-binding 
domain), Tir258–361 (containing the Intimin-binding domain), 
and H7 flagellin352–374 (EITH7), which is protective against an 
E. coli O157:H7 challenge infection in the mouse model 
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(Iannino et  al., 2015), and fused in frame with the peptide 
SlpA284–444 of L. acidophilus. The resulting EITH7-SlpA284–444 was 
recombinantly expressed and mixed with a L. acidophilus culture 
to allow the external coating of the bacteria with the STEC 
antigen, in a process that we  termed “decoration.”
The L. acidophilus S-layer is composed mainly of SlpA, 
although there are less-represented proteins such as SlpX 
(Palomino et  al., 2016). After being secreted, the S-layer 
proteins can self-assemble forming a bi-dimensional 
symmetrical structure that completely covers the bacterial 
cell wall. In L. acidophilus, SlpA, in addition to its function 
as a protective coat for the bacteria, also participates in 
host cell adhesion (Ashida et al., 2011). It has been described 
that the S-layer can be  removed from the bacterial surface 
by cation substitution solutions (LiCl) or hydrogen bond-
breaking agents such as guanidine hydrochloride (GHCl) or 
urea (Sleytr et  al., 2014). Interestingly, after dialysis, the 
isolated S-layer protein can associate back to the Lactobacillus 
cell wall or adhere to inert surfaces that can be  adapted 
for biotechnological purposes (Sleytr et al., 2014; Fina Martin 
et al., 2019). SlpA encodes in its carboxy-terminal (SlpA284–444) 
a tandem of two copies of the protein domain denominated 
SLP-A (dSLP-A), a region that was shown to be  necessary 
and sufficient for the association of SlpA to the bacterial 
cell wall (Fina Martin et  al., 2019). Teichoic acid and wall 
teichoic acid present on the lactobacilli bacterial cell wall 
have been characterized as natural ligands for the dSLP-A 
domain (Fina Martin et al., 2019). The dSLP-A domain (pfam: 
03217) is found only in Lactobacillus species, limited to 
S-layer forming lactobacilli of the L. acidophilus group, 
including Lactobacillus helveticus, Lactobacillus crispatus, 
Lactobacillus gallinarum, and Lactobacillus amylovorus (Avall-
Jaaskelainen and Palva, 2005). This domain is also found in 
S-layer associated proteins (Johnson et  al., 2013) related to 
probiotic activity, adhesion (Hymes et  al., 2016), 
immunomodulation (Johnson et  al., 2017), and cell division 
(Johnson et  al., 2016).
We evaluated the efficiency of L. acidophilus decorated with 
STEC antigens as a vaccine platform. Mice were orally immunized 
with EITH7-decorated L. acidophilus to evaluate its ability to 
elicit a protective immune response against STEC. Our results 
suggest that the antigen decoration strategy of lactobacilli can 
be  an interesting alternative as a vaccine platform.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Culture 
Conditions
Bacterial strains and plasmids used are summarized in Table 1. 
Escherichia coli strains were cultured at 37°C on Luria Bertani 
(LB) medium (Sigma, St. Louis, MO, United States) or Sorbitol 
MacConkey agar (SMAC; Britania, Argentina). Lactobacillus 
acidophilus ATCC 4356 was cultured at 37°C on DeMan, 
Ragosa, and Sharpe medium (MRS; Britania, Argentina). Bacillus 
subtilis var. natto (ATCC 15245) was cultured in LB or LB 
agar. When necessary, culture media were supplemented with 
antibiotics at the following concentrations: ampicillin 50  μg/ml, 
kanamycin 50 μg/ml, and nalidixic acid 20 μg/ml. All experiments 
involving STEC were conducted in a BSL3 facility.
Cloning, Expression, and Purification of 
Recombinant Proteins
A DNA fragment encoding for the last 160 amino acids of 
SlpA (SlpA284–444) of L. acidophilus that contains a tandem of 
two SLP-A protein domains (dSLP-A) was synthesized by 
Integrated DNA Technologies, Inc. (IDT, United  States). A 
synthetic gene encoding EspA36–192, Intimin653–953, Tir240–378, and 
flagellin H7domain (EITH7) from STEC EDL933 strain was 
synthesized by GenScript Company (United States; Iannino 
et  al., 2015). The peptide (EAAAK)4 was intervened between 
individual proteins to promote their proper folding (Iannino 
et  al., 2015). The FLAG epitope (DYKDDDDK) was fused to 
the C-terminal of EITH7 to monitor protein expression.
The DNA sequence encoding the L. acidophilus dSLP-A 
domain (SlpA284–444) was subcloned into pGEX-2T vector 
(GE-Healthcare; Table  1), and the resultant protein 
GST-dSLP-A was expressed and purified by Glutathione 
Sepharose Fast Flow (GE-Healthcare) affinity chromatography 
as described by manufacturer instruction. The encoding 
sequence of EITH7 was subcloned into pLC3 expression 
vector (Table 1) and afterward the dSLP-A encoding sequence 
was placed at the C-terminal as shown in Table  1. The 
resulting plasmid pLC3-EITH7-dSLP-A was transformed into 
E. coli BL21. Expression of EITH7-dSLP-A protein was induced 
by a final concentration of 0.25  mM of Isopropyl β-D-1-
thiogalactopyranoside (Sigma-Aldrich) and purified by amylose 
affinity chromatography (New England BioLabs) as manufacturer 
instruction.
Sequences of fliC from Salmonella enterica serovar Typhimurium 
LT2, Brucella abortus omp19, and the mouse lectin gal8 were 
cloned into pLC3-EITH7- dSLP-A, replacing EITH7 from the 
construction (Table  1). Resulting M-FliC-dSLP-A, M-Omp19-
dSLP-A, and M-Gal8-dSLP-A proteins was recombinantly expressed 
as described above and purified at the same experimental 
conditions used for M-EITH7-dSLP-A. For amplification of the 
sequences of Gal8 and Omp19 by PCR, the following primers 
were used: pFwGal8 5'-tgaCATATGgctagcatgttgtccttaaa-3', 
pRvGal8, 5'-gtaGTCGACccagctccttacatccag-3', pFwOmp19 
5'-tgaCATATGatgcagagctcccggctt-3', and pRvOmp19 5'-tgaGTCG 
ACgcgcgacagcgtcacgg-3'.
Generation of Antibodies
Eight-week-old BALB/c mice were immunized intraperitoneally 
with 10  μg of purified recombinant GST-dSLP-A protein or 
M-EITH7 protein using aluminum hydroxide (Imject Alum 
ThermoFisher) as an adjuvant and boosted at 2–4  weeks with 
5  μg of each protein. A week after the last immunization, 
mice were bled, and sera were stored at −20°C for further use.
SDS-PAGE and Western Blot Analysis
Protein samples were treated with cracking buffer (50 mM Tris-HCl 
pH 6.8, 2% wt/vol sodium dodecyl sulfate, 0.1% wt/vol bromophenol 
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blue, 10% wt/vol glycerol, and 50 mM dithiothreitol) and incubated 
at 100°C for 5 min. Protein electrophoresis separation was performed 
at 120 V for 1 h on a 10% SDS-PAGE gel. Subsequently, proteins 
were transferred to a nitrocellulose membrane using a semi-dry 
electroblotting transfer unit (Bio-Rad, Hercules, CA, United States) 
for 45  min at 15  V. After 1  h blocking buffer [0.1% Tween 20 
and 1% dry skim milk in phosphate-buffered saline (PBS) buffer], 
membranes were incubated for 1 h with the corresponding primary 
antibody. Membranes were washed four times during 5 min with 
washing buffer (0.1% Tween 20  in PBS buffer) and incubated 
for 1  h with a 1:20.000 blocking buffer dilution of IRDye 
fluorophore-labeled secondary antibodies (LI-COR, Lincoln, NE, 
United States). After washing four times, membranes were scanned 
using the Odyssey Imaging System (LI-COR).
Lactobacillus Decoration
Overnight cultures of lactobacilli were harvested by centrifugation. 
After centrifugation, the bacterial pellet was washed three times 
with cold PBS. An equal number of lactobacilli (5  ×  108  CFU) 
were resuspended and incubated for 30  min with different 
concentrations of dSLP-A-fusion proteins in a final volume of 
100 μl. Each fraction of decorated lactobacilli was washed three 
times with cold PBS. L. acidophilus was pre-treated for 15  min 
with a 5  M LiCl solution to remove the wild type SlpA. The 
same protocol was used also for decoration of B. subtilis.
Studies of Binding Stability
For studies of binding stability, decorated bacteria were subjected 
to different conditions that mimic the gastrointestinal 
environment (pH, bile acids, and protease). After being collected 
by centrifugation, L. acidophilus was washed twice with PBS 
and processed for SDS-PAGE and western blot analysis. 
GST-dSLP-A decorated bacteria were incubated 30 min at pH2 
(stomach-like conditions), 60  min at pH6.5 (proximal small 
bowel-like), 120  min at pH7.5 (mid-small bowel-like), and 
240  min at pH7.5 (distal small bowel-like; Evans et  al., 1988). 
For protease stability assay, a pancreatin (SIGMA-ALDRICH) 
concentration of 10  μg/ml was used. For bile acid stability 
were used different concentrations of bile acids (Britania; 
4–40  mg/ml) at different incubation times (10, 15, 30, and 
60  min; Pfeiler et  al., 2007).
Mouse Vaccination
Eight-week-old BALB/c mice (female) were orally immunized 
with 4 × 108 UFC of lactobacilli or 4 × 108 CFU of lactobacilli 
carrying 20 μg of M-EITH7-dSLP-A or with M-EITH7-dSLP-A 
TABLE 1 | Bacterial strains and plasmids used in this study.
Strain or plasmid Relevant phenotype or genotypea Reference or resource
Strain
E. coli
XL1-Blue MRF´ Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac [F ' proAB lacIqZΔM15 Tn10,Tetr] Stratagene
DH5α F− φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rK−, mK+) phoA supE44λ- thi-1 gyrA96 relA1 Invitrogen
BL21 Codon plus [ompT hsdS(rB– mB–) dcm + Tcr gal λ (DE3) endA Hte Cmr] Stratagen
EDL933 Reference strain of STEC O157:H7 (stx1 stx2 eae-γ) ATCC 43895
L. acidophilus Wild type strain ATCC 4356
B. subtilis Wild type strain var. natto ATCC 15245
Plasmid
pIDT-SlpA 603 bp fragment encoding last C-terminal 160 acids of SlpA protein from Lactobacillus acidophillus with a FLAG tag 
(DYKDDDDK)
IDT, United States
pGEX-2T 4.9-kb expression vector N-terminal GST tag, C-terminal FLAG-Tag, Ampr GE Healthcare
pGEX-SlpA ~600 pb BamHI/EcoRI fragment containing the synthetic C-terminal domain for Lactobacillus acidophilus SlpA protein 
cloned into pGEX-2 T, Ampr
This study
pUC57- EITH7 ~2-kb BamHI/XbaI fragment containing the synthetic genes for EspA, Intimin, Tir and flagellin H7 domain (EITH7) from 
EDL933 strain cloned into pUC57, Ampr
GenScript NJ, 
United States
pLC3 Modified form of the expression vector pET-28 d
(Novagen) with a maltose binding protein (MBP)-coding region inserted into the multiple cloning site (MCS).
Savinov et al., 2012
pLC3-EITH7 1841 pb NdeI/EcoRI restriction fragment from pUC57-EITH7 cloned into pLC3 plasmid. This study
pLC3-EITH7-SlpA 505 pb PCR product of SlpA was cloned downstream EITH7 sequence into pLC3-EITH7 plasmid using EcoRI/HindIII 
restriction sites.
This study
pET-22b-Omp19 The ORF of unlipidated Omp19 protein of Brucella abortus was cloned in the pET-22b (Novagen, Madison, WI) 
expression vector.
Ibañez et al., 2015
pLC3-Omp19-SlpA 489 pb of Omp19 PCR product were inserted into NdeI/SalI restriction sites of pLC3-EITH7-SlpA replacing EITH7 
sequence and obtaining pLC3-Omp19-SlpA plasmid.
This study
pET-22b-FliC 1,512 bp corresponding to Salmonella enterica Serovar Typhimurium LT2 were cloned in NdeI-and XhoI of pET22b. GenScript NJ, 
United States
pLC3-FliC-SlpA FliC sequence was obtained by NdeI/XhoI digestion of pET-22b-FliC vector and cloned into NdeI/SalI restriction sites 




990 pb NheI/BglII fragment containing the synthetic gen for murine Gal8 cloned into pTRC, Ampr
~990 pb of Gal8 product, obtained by PCR of pTRCHisB-Gal8, were inserted into NdeI/SalI restriction sites of pLC3-
EITH7-SlpA replacing EITH7 sequence.
This study
This study
aAmpr, ampicillin resistance; Nalr, nalidixic acid resistance; Cm, Chloramphenicol; Kanr, Kanamycin resistance.
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alone in a three doses scheme (0, 2, and 4  weeks). Prior oral 
immunization mice were fasted for 6  h and food was placed 
back 1  h after oral immunization.
Challenge of Vaccinated Mice With 
Experimental Infection of STEC 
(Escherichia coli O157:H7)
Ten days after the last immunization, mice were challenged 
by intragastric inoculation of 1010  CFU of STEC in 100  μl of 
PBS. Previously, food was removed from mouse cages 6  h 
before the oral infection challenge. Bacterial fecal shedding 
was monitored daily for over 25  days. Briefly, mouse fecal 
pellets were collected, suspended in 500  μl of PBS, serially 
diluted, and plated onto SMAC agar with 20 μg/ml of nalidixic 
acid. Culture plates were incubated at 37°C for 24  h, and 
colony-forming units (CFUs) were determined.
EITH7-Specific Antibody Determination
The 96-well plate was coated with purified M-EITH7 protein 
(Table  1; 125  ng/well) in carbonate-bicarbonate buffer pH 
9.6 for the iELISA test. To determine fecal antibodies, feces 
were resuspended in buffer PBS containing 1% of BSA 
(Sigma, St. Louis, MO, United  States), 25  mM of EDTA, 
2  mM of phenylmethylsulfonyl fluoride (PMSF; Sigma, 
St. Louis, MO, Unites States). The suspension was clarified 
by centrifugation and its supernatant diluted (1:2) and then 
used for an ELISA test during the same day. Sera samples 
were collected and stored at −20°C until use. Sera were 
1:200 diluted in the blocking buffer (0.1% Tween 20  in 
PBS buffer). To reveal antibody presence, HRP-conjugated 
anti-mouse IgA (1:500) or HRP-anti-mouse-IgG (1:1000) 
were added and incubated for 1  h at 25°C. HRP activity 
was determined with 3, 3',5,5' Tetramethylbenzidine (Sigma), 
and optical density was measured at 450  nm (OD450). A 
positive serum was generated against the EITH7 antigen 
by ip immunization that was included in all the ELISA test 
plates as an internal reference value.
Immunofluorescence Microscopy
Lactobacillus acidophilus or B. subtilis previously decorated 
with dSLP-A-tagged proteins were incubated during 30  min 
on coverslips pretreated with poly-L-Lysine (Sigma, St. Louis, 
MO, United  States) to allow the bacterial adhesion. After 
washing twice with PBS, samples were fixed with PFA (4% 
in PBS) for 15  min at room temperature. After fixation, 
coverslips were washed twice with PBS, and the remaining 
PFA was quenched by incubation with 50 mM NH4Cl (Sigma, 
St. Louis, MO, United States) for 1 h or overnight. Coverslips 
were washed with PBS and blocked during 1  h with 10% 
Bovine Serum Albumin (Sigma, St. Louis, MO, United States) 
in PBS. Later, covers were incubated 1  h with anti-EITH7 
mouse sera diluted (1:500) in blocking buffer, washed with 
PBS, and incubated 1  h more with an ALEXA488- anti-IgG 
conjugated (ThermoFisher), diluted (1:10000) in blocking 
buffer. Finally, samples were examined with a confocal 
laser-scanning microscope Olympus FV1000 using a PlanApo 
N (60  ×  1.42  NA) oil objective.
Statistical Analysis
One-way ANOVA with Bonferroni post hoc test and Student’s 
t-test (GraphPad Software) was used for statistical analysis.
Ethics Statement
Experimental procedure of this study (permit number 15/2018) 
was approved by the Committee on the Ethics of Animal 
Experiments of the Universidad Nacional de San Martín 
(UNSAM), under the recommendations for animal 
experimentation (Helsinki Declaration and its amendments, 
Amsterdam Protocol of welfare and animal protection and 
National Institutes of Health, United  States NIH, guidelines: 
Guide for the Care and Use of Laboratory Animals).
RESULTS
Proteins Fused in Frame With the dSLP-A 
Protein Domain Can Associate With the 
Surface of L. acidophilus
To analyze the presence of conserved protein domains within 
the SlpA amino acid sequence, a BLAST search was performed. 
As shown in Figure 1A, two copies of a 60-amino acids protein 
domain denominated SLP-A (pfam03217; Figure  1A; Boot 
et  al., 1995) were identified within de carboxy- terminal of 
SlpA. Both copies of the SLP-A domain (dSLP-A) are required 
for an efficient cell wall binding of SlpA to the surface of 
L. acidophilus (Fina Martin et  al., 2019). In addition, as shown 
in Figure  1A, the amino-terminal of SlpA (SlpA1–31) encodes 
a predicted signal peptide (analyzed by a deep neural network-
based method SignalP-5.0) and the peptide region SlpA31–284 
for a Herpes BLLF1 protein domain (pfam05109), a protein 
region that has been shown to be  required for self-assembly 
of SlpA on the bacterial surface to form the S-layer (Smit 
et  al., 2002). As shown in the scheme presented in Figure  1A, 
an expression vector was constructed for fusing in frame any 
heterologous proteins (h-proteins) of interest with the dSLP-A 
domain. Also, the sequence of the FLAG epitope was inserted 
between the heterologous protein of interest and the dSLP-A 
domain as a reporter tag. As shown in Figure 1B and Table 1, 
two different plasmids backbones were used for cloning proteins 
of interest, fused to the dSLP-A domain: the pLC3 (Savinov 
et  al., 2012) and the plasmid pGEX-2T that allows the fusion 
of polypeptides with the maltose-binding protein (MBP) or 
the glutathione S-tranferase (GST), respectively, both for affinity 
purification purposes. Consequently, a set of dSLP-A-fused 
proteins were constructed and were used here (Figure  1B). 
As shown in Figure 1C, three different examples of heterologous 
proteins such as the Brucella protease inhibitor Omp19 (Ibañez 
et  al., 2015), the Salmonella flagellin FliC (Mcclelland et  al., 
2001), and the mouse lectin GAL8 (Tribulatti et  al., 2007) 
fused to the dSLP-A domain were able to efficiently bind to 
108  CFU of L. acidophilus.
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FIGURE 1 | (A) The scheme shows all the protein domains detected in the sequence of the protein L. acidophilus SlpA predicted by the NCBI BLAST program. 
The binding domain named dSLP-A is formed by a tandem of two copies of the SLP-A domain (pfam03217): SLP-A1 and SLP-A2. SlpA1–31 encodes for a 
secretion signal sequence predicted by SignalP-5.0 (SP). In SlpA 31–284 region, a Herpes BLLF1 domain was detected (pfam05109). A cartoon showing the 
decoration process is presented which includes the expression vector used for tagging different heterologous proteins (h-PROTEIN) with the dSLP-A domain.  
(B) Different constructions used in this report. (C) Western blot analysis shows the increasing association of dSLP-A-tagged proteins to the Lactobacillus cell 
wall that correlates with the increasing concentration of these proteins in the incubation solution. TransGen Biotech Pre-stained markers blue-Plus Pre-stained 
markers 120, 100, 70, 50, 40, 30, 25, and 14 kDa. GST, glutathione S-transferase; MBP, maltose-binding protein; F, FLAG epitope; H, Escherichia coli H7 
epitope.
Adhesion of GST-dSLP-A Reporter Protein 
to the L. acidophilus Cell Wall Is Stable at 
Conditions That Mimic the Traffic Across 
the Intestinal Tract
As described in Table  1, the sequence of the dSLP-A domain 
was inserted in pGEX-2T to construct the reporter protein 
GST-dSLP-A (Figure  1B). Lactobacillus acidophilus decorated 
with GST-dSLP-A were subjected to environmental conditions 
that bacteria encounter during the transit through the intestinal 
tract (pH variations, bile salts, or degradation by intestinal 
proteases) to evaluate the stability of dSLP-A binding in these 
conditions (Figure  2).
As shown in Figure 2A, GST-dSLP-A coating of L. acidophilus 
follows a saturation curve reaching a plateau at micromolar 
concentrations. The stability of the GST-dSLP-A association 
with L. acidophilus wall was tested in the environmental 
conditions mimicking different portions of the human intestinal 
tract (stomach, duodenum, jejunum, and ileum) in terms of 
pH and time of transit through the intestinal tract (Evans 
et  al., 1988). As shown in Figure  2B, GST-dSLP-A (INPUT) 
binding to L. acidophilus was stable for 30  min at pH 2 and 
37°C, a condition that resembles the stomach-like environment. 
In addition, the stability of GST-dSLP-A bacterial association 
at proximal small bowel-like conditions (1  h, pH 6.5–37°C), 
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mid-small bowel-like conditions (2 h, pH 7.5–37°C), and distal 
small bowel-like conditions (4  h, pH 7.5–37°C) was partially 
affected compared against the input control (p  <  0.001; 
Figure  2B). No significant difference was detected between 
treatments at pH 6.5/37°C, 2 h or 4 h at pH7.5/37°C. Interestingly, 
GST-dSLP-A association with L. acidophilus was not affected 
by increasing concentration of bile salts even when the 
concentration was five times higher than physiological 
concentrations (Supplementary Figure S1; Pfeiler et al., 2007).
As shown in Figure  2C, binding of GST-dSLP-A to 
L. acidophilus protected the degradation of this protein when 
incubated with the digestive enzymes cocktail named Pancreatin 
(containing trypsin, chymotrypsin, pepsin, pancreatin, and 
elastase) compared with an equivalent amount of non-associated 
GST-dSLP-A. Free GST-dSLP-A was degraded close to 10 times 
faster than GST-dSLP-A bound to L. acidophilus.
The Chimeric Antigen EITH7-dSLP-A Binds 
to L. acidophilus Surface Following A 
Saturation Curve
To evaluate the possibility of using L. acidophilus as an antigen 
delivery system, the chimeric antigen EspA36–192-Intimin653–
953-Tir240–378 H7-flagellin352–374 (EITH7; from E. coli O157:H7 
EDL933) was constructed by gene synthesis as described in 
the section Materials and Methods, fused in frame with the 
dSLP-A domain and subcloned into the pLC3 expression vector 
(MBP-EspA36–192-Intimin653–953-Tir240–378- H7-flagellin352–374 SlpA284–444 
or M-EITH7-dSLP-A; Figure  1B). As shown in Figure  3A, 
the protein M-EITH7-dSLP-A strongly associated with the cell 
wall of L. acidophilus with a similar saturation curve as the 
one observed with GST-dSLP-A (Figure  2A).
As described in the section Material and Methods, 
we  estimated that 108 cells of L. acidophilus were able to load 
up to 30  μg of protein M-EITH7-dSLP-A (Figure  3A, lower 
panel). Interestingly, to remove the recombinant S-layer attached 
to L. acidophilus cell wall formed by M-EITH7-dSLP-A, it was 
necessary to treat the antigen decorated bacteria with chaotropic 
solutions (5 M LiCl), with the same stringent conditions required 
for removing the wild type S-layer (Figure  3B).
To determine the strict requirement of dSLP-A domain for 
the binding specificity of M-EITH7-dSLP-A to L. acidophilus, 
cultures of these bacteria were incubated with M-EITH7 (without 
dSLP-A, see Figure  1B) or M-EITH7-dSLP-A (Figure  3C). 
Figure  3C shows that incubation with L. acidophilus retained 
proteins with high specificity from a protein lysate input only 
when dSLP-A was present in the construct (see input vs. 
unbound fraction). Accordingly, elution with 5  M LiCl only 
released proteins in the case of M-EITH7-dSLP-A indicating 
that the binding was dependent on the dSLP-A domain. When 
observed by immune-fluorescence confocal microscopy, it was 
possible to determine that M-EITH7-dSLP-A completely coated 
the surface of the bacteria L. acidophilus with a homogeneous 
distribution (Figure  3D).
Teichoic acid and wall teichoic acid which are present on the 
lactobacilli bacterial cell wall have been characterized as natural 
ligands for the dSLP-A domain (Fina Martin et  al., 2019). 
A B C
FIGURE 2 | (A) Western blot analysis revealed with the Odyssey system (up panel), and its quantification (down panel) using the Image Studio software showing 
the association of the protein GST-dSLP-A to the surface of 108 cells of L. acidophilus. Increasing concentrations of GST-dSLP-A (at μM concentration) correlates 
with the increasing amount of this protein associated with the bacterial cell wall that follows a typical saturation curve. (B) Western blot showing the amount of 
retained GST-dSLP-A on the bacterial cell wall after the incubation for 30 min at pH2 (stomach-like conditions), 60 min at pH6.5 (proximal small bowel-like), 120 min 
at pH7.5 (mid-small bowel-like), and 240 min at pH7.5 (distal small bowel-like) compared with the control (INPUT; up panel). Quantification is shown in the down 
panel. One way ANOVA test and Bonferroni post hoc test were performed to analyze the statistical significance of these results (***p < 0.001). (C) Western blot 
analysis comparing the speed of degradation of GST-dSLP-A bound to L. acidophilus or GST-dSLP-A free in solution incubated with pancreatin (free vs. bound). 
Arrow indicates the migration of GST-dSLP-A (47.2 kDa). Thermo Scientific Pre-stained markers 180, 130, 100, 70, 55, 40, 35, 25, 15, and 10 kDa. Results shown 
are representative of two independent experiments.
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FIGURE 3 | (A) Western blot (up panel) and its quantification (down panel) showing the association of the MBP-EITH7-dSLP-A to 108 cells of L. acidophilus. 
Incubation with increasing concentration of MBP-EITH7-dSLP-A correlates with the increment in the association of this protein to the bacterial cell wall that follows a 
typical saturation curve. As described, by comparison with a standard curve that correlates micrograms of proteins with the log10 of the fluorescence is possible to 
convert fluorescence to micrograms of MBP-EITH7-dSLP-A bound to Lactobacillus (down panel). (B) SDS-PAGE analysis was performed to evaluate the binding of 
MBP-EITH7-dSLP-A to Lactobacillus. Purified MBP-EITH7-dSLP-A was incubated with 108 bacteria for 30 min at 4°C and afterward centrifuged to separate 
bacterial pellet from the protein input solution. After two washes the pellet was subjected to 5 M LiCl to elute bacterium-associated proteins. (C) To control binding 
specificity of MBP-EITH7-dSLAP to Lactobacillus, proteins MBP-EITH7 (as a negative control) and MBP-EITH7-dSLP-A were incubated with 108 bacteria for 30 min 
at 37°C, centrifuged, and the bacterial pellet were washed twice and resuspended in 5 M LiCl to elute protein associated to Lactobacillus. (D) Immune-fluorescence 
using an anti-EITH7 antibody. Confocal microscopy shows the homogenous distribution of MBP-EITH7 on the L. acidophilus surface after decoration. TransGen 
Biotech Pre-stained markers blue-Plus Pre-stained markers 120, 100, 70, 50, 40, 30, 25, and 14 kDa.
Therefore, it is conceivable to expect that, in addition to L. 
acidophilus, dSLP-A-tagged proteins could bind also to any 
bacteria that display teichoic acids on its cell wall. Thus, dSLP-
A-tagged proteins (GST-dSLP-A and M-EITH7-SLP-A) were 
also able to associate with B. subtilis var. natto (also a GRAS 
microorganism; Figure 4A). Association of the chimeric antigen 
M-EITH7-SLP-A to the surface of B. subtilis natto was also 
confirmed by confocal microscopy (Figure  4B).
Mice Orally Immunized With L. acidophilus 
Decorated With M-EITH7-dSLP-A Elicited 
An Early Humoral and Mucosal Immune 
Response
Figure  5A shows a diagram of the immunization protocol 
used. BALB/c mice were immunized with three oral doses of 
different antigenic preparations (at 0, 2, and 4  weeks) and 
afterward (6  weeks post-immunization), all the immunized 
groups were experimentally challenged with 1010  CFU of 
E. coli O157:H7. Interestingly, after the first dose of M-EITH7-
dSLP-A associated to L. acidophilus (10 days post-immunization), 
a significant increase in fecal EITH7-specific antibodies (IgA) 
was detected compared with the oral administration of the 
free M-EITH7-dSLP-A antigen or L. acidophilus alone used 
as a negative control. Similar results were also observed at 
20  days after the first immunization (10  days after the second 
immunization; Figure 5B). In addition, the presence of EITH7-
specific antibodies (IgG and IgA) in mouse sera was also 
determined by ELISA (Figure  6). A significant increase of 
anti-EITH7 titers in sera, IgG (Figure 6A), and IgA antibodies 
(Figure 6B) was detected 10 days post-immunization although 
at 20  days post-immunization only anti-EITH7 IgG was 
significantly increased. Of relevance, oral administration of wild 
type L. acidophilus that naturally carries a full-length SlpA 
(our negative control) or the administration of the free antigen 
M-EITH7-dSLP-A (Figure  6B, M-EITH7-dSLP-Afree) elicited 
no significant increase in IgA titers in feces (Figure  5B) or 
in sera (Figure  6). Altogether, these results indicate that only 
oral administration of M-EITH7-dSLP-A carried by L. acidophilus 
was able to induce a significant mucosal and humoral immune 
response against the EITH7 antigen. These results suggest that 
the association of EITH7 to L. acidophilus allows the effective 
delivery of the antigen to the competent sites for an effective 
antigen presentation to induce a specific immune response.
Mice Immunized With M-EITH7-dSLP-A-  
L. acidophilus Efficiently Control A STEC 
Challenge Infection
As shown in Figures 5, 6, induction of a mucosal and humoral 
immune response in mice required the administration of the 
antigen M-EITH7-dSLP-A bound to L. acidophilus while either 
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the free M-EITH7-dSLP-A or L. acidophilus were not sufficient 
to elicit an EITH7-specific immune response. To determine if 
this antibody immune response correlated with an effective 
protection against an experimental infection with E. coli O157:H7, 
mice were immunized with different preparations and orally 
challenged with 1010  CFU of STEC.
Bacterial fecal shedding was determined to estimate the efficiency 
of protection elicited by the antigen preparation. As shown in 
Figure  7, mice immunized with either the antigen decorated 
L. acidophilus-(M-EITH7-dSLP-A; white dots) or with L. acidophilus 
(black dots) shed equivalent levels of STEC in mouse feces during 
the first-week post-challenge. Interestingly, after 11  days post-
challenge, a significant reduction in fecal shedding was observed 
in the group that received L. acidophilus-(M-EITH7-dSLP-A) 
compared with the control group. Mice that received the carrier 
L. acidophilus alone kept shedding more than 104 STEC/g in 
feces for almost 3  weeks post-challenge while the group that 
received antigen-decorated L. acidophilus-(M-EITH7-dSLP-A) shed 
less than 102 STEC/g at the same time post-challenge. These 
results indicate that the EITH7 antigen delivered by Lactobacillus 
as a vaccine carrier was able to induce a protective immune 
response that correlates with the differential immune response 
observed.
DISCUSSION
It has been described that strains of Lactobacillus can stimulate 
the specific and the innate immune responses and, consequently, 
have been proposed as vaccine carriers (Pardo et  al., 2016; 
Szatraj et  al., 2017; Lecureux and Dean, 2018). Activation of 
the innate immune response is mediated by the PRRs expressed 
on immune cells that recognize conserved molecular structures 
known as MAMPs that activate the production of cytokines, 
chemokines, and other innate effectors. Host recognition of 
Lactobacillus is predominantly mediated by TLR2 receptor that 
A
B
FIGURE 4 | (A) Western blot analysis shows the increased binding of GST-dSLP-A (left) or MBP-EITH7-dSLP-A (right) to Bacillus subtilis surface that correlates 
with the increasing concentration of these proteins in the incubation solution. (Mk) Pre-stained molecular markers. (B) Confocal immunofluorescence microscopy of 
B. subtilis (upper panel) or B. subtilis decorated with MBP-EITH7-dSLP-A (lower panel) revealed with anti-EITH7 as the primary antibody.
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FIGURE 5 | (A) Scheme of immunization and study of vaccine protection against a challenging infection in a mouse model. (B) BALB/c mice were orally immunized 
with free 20 μg of MBP-EITH7-dSLP-A, 4 × 108 UFC of lactobacilli, or 4 × 108 CFU of lactobacilli decorated with 20 μg of MBP-EITH7-dSLP-A in a scheme of three 
doses. Indirect ELISA for detection of mucosal IgA in feces (n = 6) was performed at 10 and 20 days post-immunization. A reference positive serum against EITH7 
generated by i.p. immunization was used as a positive control (POS). One way ANOVA and Bonferroni’s Multiple Comparison post hoc Test (*p < 0.05), (***p < 0.01), 
and (***p < 0.001) was performed to analyze the statistical significance of results. Results shown are representative of three independent experiments.
recognizes teichoic and lipoteichoich acids which are present 
in the Lactobacillus cell wall leading to maturation of dendritic 
cells (Konstantinov et  al., 2008) and the differentiation of 
monocytic precursors to Langerhans-like cells (Song et  al., 
2018). Also, it was shown that the L. acidophilus S-layer protein 
is able to interact with the DC-SIGN receptor (Dendritic Cell-
Specific Intercellular adhesion molecule-3-Grabbing Non-integrin; 
CD209) a major dendritic cell receptor, interfering with the 
association of several human viruses such as HIV (Petrova 
et  al., 2013) and JUNV (Martinez et  al., 2012).
Here, we  report the adaptation of L. acidophilus to deliver 
antigens to the gastrointestinal mucosa. Traditionally, 
Lactobacillus species have been engineered to express viral and 
bacterial antigens to elicit protective immune responses (Lecureux 
and Dean, 2018). This approach has a regulatory problem as 
it generates GMOs that are strictly regulated by several 
government offices (Directive 2001/18/EC of the European 
Parliament) if they will be  released to the environment. In 
our system, antigens are passively attached to the surface of 
L. acidophilus with no alteration of the genotype and, therefore, 
with no generation of GMO microorganisms. For this reason, 
vaccine candidates based on this antigen decoration strategy 
are expected to have an easier, faster, and less-expensive 
regulatory approval process. Taking this into consideration, 
we  studied if this strategy is suitable for the development of 
a vaccine candidate against the STEC. STEC infections can 
induce the development of the HUS, particularly in children 
below 5-year old that are the most susceptible population group 
(Fernandez-Brando et  al., 2017). In addition to the severe 
consequences of HUS in children, it is also important to 
mention the economical burden that this disease represents 
for Public Health (e.g., STEC infection is a recurrent cause 
for kidney transplant in children and young people). Despite 
all these problems, there are no approved therapies or licensed 
vaccines against this bacterial infection for human use. The 
development of a safe oral vaccine could be of critical relevance 
for preventing HUS in children. Recently, two papers have 
proposed the adaptation of Lactobacillus for STEC vaccine 
development (Ferreira et  al., 2011; Lin et  al., 2017). In one 
of these reports, Lin et  al. (2017) engineered L. acidophilus 
to express a chimeric STEC antigen composed by EspA and 
Tir (named E-T) with a signal peptide for the secretion to 
the bacterial supernatant. Interestingly, these authors have shown 
that E-T-vaccinated mice were protected against an experimental 
infection (1010 E. coli O157), similar to what we  have shown 
here. Interestingly, although the fecal immune response 
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(determined by ELISA signal) was similar to our results, 
immunization with E-T secreting-Lactobacillus induced an 
antibody immune response in sera than was relatively much 
stronger than the one we  observed (Figure  6). It is interesting 
to speculate if these discrepancies between results could 
be  reflecting differences in antigen dose since a recombinant 
strain of Lactobacillus has the capacity to express the heterologous 
antigens after it replicates. In our case, antigen-decorated bacteria 
are limited to a one-shot opportunity to deliver its cargo to 
the mucosal tissues, since the de novo expression of the 
recombinant antigen is not possible. This limitation could 
be  sorted out either by optimizing the amount of antigen to 
be  delivered increasing the number of decorated bacteria or 
by augmenting the number of doses. Since the amount of 
decorating antigen can be  finely tuned and monitored it is 
possible to optimize the immunization protocol to induce a 
more effective immune response. Additionally, the system can 
be  improved since it allows the co-decoration of L. acidophilus 
with proteins with different activities like immune modulators 
such as the TLR5-agonist of Salmonella flagellin, the lectin 
GAL8, or with the protease inhibitor B. abortus Omp19. 
Interestingly, all these molecules can modulate the induction 
of the immune response by altering the way that antigens are 
presented to the immune system, enhancing its half-life, or 
providing a particular environment of cytokines for a more 
efficient antigen presentation. As shown here, the fusion of 
the dSLP-A domains to all protein tested allows the adhesion 
of the resulting chimera protein to the surface of L. acidophilus. 
As shown in Figure  4, in addition to L. acidophilus, 
dSLP-A-tagged proteins can also bind to different bacteria 
that display teichoic acids on its cell wall such as B. subtilis. 
This could be  particularly useful to optimize a prime/boost 
immunization strategy by simply switching the bacterial carrier 
when a second dose is required. BLAST sequence analysis 
showed that L. acidophilus dSLP-A domain displays more than 
75% amino acid identity to SlpA sequences present in 
L. helveticus, L. crispatus, L. amyolovorus, and L. gallinarum 
(Supplementary Table S1). Since L. helveticus and L. crispatus 
are vaginal mucosa resident bacteria (Nunn and Forney, 2016), 
it could be  interesting to explore if they can be  adapted as 
vaccine carriers for the induction of protective immune responses 
at genital mucosa against sexually transmitted diseases like 
HBV, HPV, or HIV.
In this report, and as a proof of concept, we  demonstrated 
that L. acidophilus could be  adapted as a vaccine carrier by 
coating the bacteria with antigens from a microbial pathogen 




FIGURE 6 | Indirect ELISA for the detection of serum anti-EITH7 specific IgG (A) and IgA (B) antibodies (n = 6). A reference positive serum against EITH7 generated by 
i.p. immunization, as described in the section Materials and Methods, was used as a POS. One way ANOVA and Bonferroni’s Multiple Comparison Test was used to 
analyze the statistical significance of results. Results shown are representative of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001.
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CONCLUSION
Here, we  have explored the adaptation of a GRAS bacterium 
such as L. acidophilus as an antigen delivery system. Decoration 
of the L. acidophilus with heterologous proteins might allow 
the development of a universal platform for intestinal delivery 
of proteins or enzymes with therapeutic value. Of interest, all 
these biotechnological applications will be  achieved without 
the generation of genetically modified bacteria or the introduction 
of antibiotic resistances.
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